Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
Oncotarget (2015) - Comment
pubmed: 26517691  doi: 10.18632/oncotarget.6241  issn: 1949-2553 

David W. Greening, Sze Ting Lee, Hong Ji, Richard J. Simpson, Angela Rigopoulos, Carmel Murone, Catherine Fang, Sylvia Gong, Graeme O'Keefe, Andrew M. Scott